Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4870359 | 1.00 | MCL1 (0.46) | MCL1KMT2ACYP1A2CYP2C19MEN1 | |
| SCHEMBL606795 | 1.00 | MCL1 (0.46) | MCL1KMT2ACYP1A2CYP2C19MEN1 | |
| SCHEMBL4870232 | 1.00 | MCL1 (0.46) | MCL1KMT2ACYP1A2CYP2C19MEN1 | |
| SCHEMBL5948112 | 1.00 | MCL1 (0.46) | MCL1KMT2ACYP1A2CYP2C19MEN1 | |
| SCHEMBL4868786 | 1.00 | MCL1 (0.46) | MCL1KMT2ACYP1A2CYP2C19MEN1 | |
| SCHEMBL8646663 | 0.97 | MCL1 (0.48) | MCL1KMT2ACYP1A2CYP2C19MEN1 | |
| SCHEMBL909621 | 0.97 | — | — | |
| SCHEMBL27789152 | 0.95 | — | — | |
| SCHEMBL3106710 | 0.90 | — | — | |
| SCHEMBL20331751 | 0.88 | FAAH (0.58) | KMT2ACYP1A2CYP2C19MEN1SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111936461-B | Process for producing dicyanoalkane and bis (aminomethyl) alkane | 三菱瓦斯化学株式会社 | 2023-09-05 | — | — | CN | disclosed |
| US-11542222-B2 | Method for preparing dicyanoalkane and bis(aminomethyl) alkane | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-01-03 | — | — | US | disclosed |
| US-20210139408-A1 | METHOD FOR PREPARING DICYANOALKANE AND BIS(AMINOMETHYL)ALKANE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-05-13 | — | — | US | disclosed |
| EP-3778559-A1 | METHOD FOR PREPARING DICYANOALKANE AND BIS(AMINOMETHYL)ALKANE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-02-17 | — | — | EP | disclosed |
| CN-111936461-A | Process for producing dicyanoalkane and bis (aminomethyl) alkane | 三菱瓦斯化学株式会社 | 2020-11-13 | — | — | CN | disclosed |
| WO-2019198782-A1 | METHOD FOR PREPARING DICYANOALKANE AND BIS(AMINOMETHYL)ALKANE | 三菱瓦斯化学株式会社 | 2019-10-17 | — | — | WO | disclosed |
| US-9233115-B2 | Proteasome inhibitors and methods of using the same | MILLENNIUM PHARMACEUTICALS INC. (US) | 2016-01-12 | — | — | US | disclosed |
| US-20140088042-A1 | Proteasome Inhibitors And Methods Of Using The Same | CEPHALON, INC. (US) | 2014-03-27 | — | — | US | disclosed |
| US-8546608-B2 | Proteasome inhibitors and methods of using the same | CEPHALON, INC. (US) | 2013-10-01 | — | — | US | disclosed |
| US-20120041196-A1 | Proteasome Inhibitors and Methods of Using the Same | CEPHALON, INC. (US) | 2012-02-16 | — | — | US | disclosed |
| US-7576206-B2 | Proteasome inhibitors and methods of using the same | CEPHALON, INC. (US) | 2009-08-18 | — | — | US | disclosed |
| EP-1658255-B1 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON INC (US) | 2009-02-18 | — | — | EP | disclosed |
| US-7470765-B2 | Method for producing polyamides | BASF AKTIENGESELLSCHAFT (DE) | 2008-12-30 | — | — | US | disclosed |
| US-7223745-B2 | Proteasome inhibitors and methods of using the same | CEPHALON, INC. (US) | 2007-05-29 | — | — | US | disclosed |
| US-20060217522-A1 | Method for the production of polyamides | BASF AKTIENGESELLSCAFT PATENTS, TRADEMARKS AND LICENSES (DE) | 2006-09-28 | — | — | US | disclosed |
| EP-1658255-A2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2006-05-24 | — | — | EP | disclosed |
| US-20050154182-A1 | Reacting mixture of nitrile-containing monomers and water in presence of titanium dioxide catalyst | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-14 | — | — | US | disclosed |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-19 | — | — | US | disclosed |
| US-20050059636-A1 | Proteasome inhibitors and methods of using the same | CEPHALON, INC. | 2005-03-17 | — | — | US | disclosed |
| WO-2005016859-A2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON, INC. (US) | 2005-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139408-A1 | METHOD FOR PREPARING DICYANOALKANE AND BIS(AMINOMETHYL)ALKANE | AADAT, DDC, ALB | MCL1 1124/4885KMT2A 265/4885CYP1A2 1253/4885 |
| US-20120041196-A1 | Proteasome Inhibitors and Methods of Using the Same | PSMB11, PSMB5, PSMB6 | MCL1 60/4885KMT2A 2266/4885CYP1A2 4407/4885 |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | PSMB11, PSMB5, PSMB6 | MCL1 60/4885KMT2A 2266/4885CYP1A2 4407/4885 |
| US-11542222-B2 | Method for preparing dicyanoalkane and bis(aminomethyl) alkane | AADAT, DDC, ALB | MCL1 1124/4885KMT2A 265/4885CYP1A2 1253/4885 |
| US-20140088042-A1 | Proteasome Inhibitors And Methods Of Using The Same | PSMB11, PSMB5, PSMB6 | MCL1 60/4885KMT2A 2266/4885CYP1A2 4407/4885 |
| US-20050059636-A1 | Proteasome inhibitors and methods of using the same | PSMB11, PSMB5, PSMB6 | MCL1 60/4885KMT2A 2266/4885CYP1A2 4407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.